Hironori Ohdaira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hironori Ohdaira has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Masashi Yoshida
Department of Surgery
18 shared publications - Yutaka Suzuki
Department of Surgery, International University of Health and Welfare Hospital, 537-3 Iguchi, Nasushiobara 329-2763, Japan
18 shared publications - Teppei Kamada
Department of Surgery The Jikei University School of Medicine Tokyo Japan
15 shared publications - Norihiko Suzuki
Department of Surgery, International University of Health and Welfare Hospital, Nasushiobara City, Japan
12 shared publications - Mitsuyoshi Urashima
Division of Molecular Epidemiology, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-Ku, Tokyo 105-8461, Japan
10 shared publications - Takashi Kohmura
Jikei University School of Medicine 1 Division of Molecular Epidemiology Tokyo, Japan
10 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Effect of Vitamin D Supplementation Stratified by Quintiles of Vitamin A
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Effect of Vitamin D Supplementation Stratified by Quintiles of Vitamin A
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Cumulative hazard Stratified by Median Serum Vitamin A Level
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Cumulative hazard Stratified by Median Serum Vitamin A Level
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Background:Vitamin D interacts with vitamin A through receptor heterodimerization. This post hoc analysis of the AMATERASU randomized clinical trial (RCT) of vitamin D3 supplementation examined whether serum vitamin A levels modify the association of vitamin D with relapse or death in patients with digestive tract cancer.Methods:The primary outcome was relapse or death. Relapse-free survival (RFS) was evaluated using Nelson–Aalen cumulative hazard functions and Cox proportional hazards models. Serum vitamin A levels were categorized stepwise using clinical reference ranges and quantile cutoffs (halves, tertiles, quartiles, quintiles, and deciles), with post hoc grouping of the most coherent quantiles for analysis.Results:Among 363 patients (mean age, 66 years; 67.8% male), serum vitamin A ranged from 0.15 to 4.30 μmol/L [median (IQR), 1.38 (1.05–1.74)] and correlated positively with 25-hydroxyvitamin D (ρ = 0.31; P < 0.0001). Patients in the lowest decile had higher relapse or death risk [HR, 2.05; 95% confidence interval (CI), 1.10–3.84; P = 0.03] than those in deciles 2 to 10. In the middle range (deciles 6–8), 5-year RFS was greater with vitamin D versus placebo (81.4% vs. 54.9%; HR, 0.31; 95% CI, 0.14–0.69; P = 0.004), with no effect in lower (deciles 1–5) or higher (deciles 9–10) ranges (Pinteraction = 0.008).Conclusions:Vitamin D supplementation may reduce relapse and death among patients with middle-to-upper range of serum vitamin A levels.Impact:These exploratory findings provide the first RCT evidence that serum vitamin A levels modify the effect of vitamin D supplementation on relapse or death among patients with digestive tract cancer.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Background:Vitamin D interacts with vitamin A through receptor heterodimerization. This post hoc analysis of the AMATERASU randomized clinical trial (RCT) of vitamin D3 supplementation examined whether serum vitamin A levels modify the association of vitamin D with relapse or death in patients with digestive tract cancer.Methods:The primary outcome was relapse or death. Relapse-free survival (RFS) was evaluated using Nelson–Aalen cumulative hazard functions and Cox proportional hazards models. Serum vitamin A levels were categorized stepwise using clinical reference ranges and quantile cutoffs (halves, tertiles, quartiles, quintiles, and deciles), with post hoc grouping of the most coherent quantiles for analysis.Results:Among 363 patients (mean age, 66 years; 67.8% male), serum vitamin A ranged from 0.15 to 4.30 μmol/L [median (IQR), 1.38 (1.05–1.74)] and correlated positively with 25-hydroxyvitamin D (ρ = 0.31; P < 0.0001). Patients in the lowest decile had higher relapse or death risk [HR, 2.05; 95% confidence interval (CI), 1.10–3.84; P = 0.03] than those in deciles 2 to 10. In the middle range (deciles 6–8), 5-year RFS was greater with vitamin D versus placebo (81.4% vs. 54.9%; HR, 0.31; 95% CI, 0.14–0.69; P = 0.004), with no effect in lower (deciles 1–5) or higher (deciles 9–10) ranges (Pinteraction = 0.008).Conclusions:Vitamin D supplementation may reduce relapse and death among patients with middle-to-upper range of serum vitamin A levels.Impact:These exploratory findings provide the first RCT evidence that serum vitamin A levels modify the effect of vitamin D supplementation on relapse or death among patients with digestive tract cancer.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Distribution and Association of Serum Vitamin A and Vitamin D Levels.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Distribution and Association of Serum Vitamin A and Vitamin D Levels.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Sup Materials and Methods from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Supplementary material shows the study protocol.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSup Materials and Methods from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Supplementary material shows the study protocol.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Effect of Vitamin D Supplementation Stratified by Tertiles of Vitamin A
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Effect of Vitamin D Supplementation Stratified by Tertiles of Vitamin A
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Effect of Vitamin D Supplementation Stratified by Quartiles of Vitamin A
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Effect of Vitamin D Supplementation Stratified by Quartiles of Vitamin A
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Effect of Vitamin D Supplementation Stratified by Clinical Reference Ranges of Vitamin A
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Effect of Vitamin D Supplementation Stratified by Clinical Reference Ranges of Vitamin A
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Effect of Vitamin D Supplementation Stratified by Deciles of Vitamin A
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Effect of Vitamin D Supplementation Stratified by Deciles of Vitamin A
- 12 January 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (3) , 429-437
Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Background: Vitamin D interacts with vitamin A through receptor heterodimerization. This post hoc analysis of the AMATERASU randomized clinical trial (RCT) of vitamin D3 supplementation examined whether serum vitamin A levels modify the association of vitamin D with relapse or death in patients with digestive tract cancer. Methods: The primary outcome was relapse or death. Relapse-free survival (RFS) was evaluated using Nelson–Aalen cumulative hazard functions and Cox proportional hazards models. Serum vitamin A levels were categorized stepwise using clinical reference ranges and quantile cutoffs (halves, tertiles, quartiles, quintiles, and deciles), with post hoc grouping of the most coherent quantiles for analysis. Results: Among 363 patients (mean age, 66 years; 67.8% male), serum vitamin A ranged from 0.15 to 4.30 μmol/L [median (IQR), 1.38 (1.05–1.74)] and correlated positively with 25-hydroxyvitamin D (ρ = 0.31; P < 0.0001). Patients in the lowest decile had higher relapse or death risk [HR, 2.05; 95% confidence interval (CI), 1.10–3.84; P = 0.03] than those in deciles 2 to 10. In the middle range (deciles 6–8), 5-year RFS was greater with vitamin D versus placebo (81.4% vs. 54.9%; HR, 0.31; 95% CI, 0.14–0.69; P = 0.004), with no effect in lower (deciles 1–5) or higher (deciles 9–10) ranges (Pinteraction = 0.008). Conclusions: Vitamin D supplementation may reduce relapse and death among patients with middle-to-upper range of serum vitamin A levels. Impact: These exploratory findings provide the first RCT evidence that serum vitamin A levels modify the effect of vitamin D supplementation on relapse or death among patients with digestive tract cancer.
- 12 January 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (3) , 429-437
Effect Modification by Serum Vitamin A Levels on the Association between Vitamin D and Relapse or Death in Patients with Digestive Tract Cancer
Background: Vitamin D interacts with vitamin A through receptor heterodimerization. This post hoc analysis of the AMATERASU randomized clinical trial (RCT) of vitamin D3 supplementation examined whether serum vitamin A levels modify the association of vitamin D with relapse or death in patients with digestive tract cancer. Methods: The primary outcome was relapse or death. Relapse-free survival (RFS) was evaluated using Nelson–Aalen cumulative hazard functions and Cox proportional hazards models. Serum vitamin A levels were categorized stepwise using clinical reference ranges and quantile cutoffs (halves, tertiles, quartiles, quintiles, and deciles), with post hoc grouping of the most coherent quantiles for analysis. Results: Among 363 patients (mean age, 66 years; 67.8% male), serum vitamin A ranged from 0.15 to 4.30 μmol/L [median (IQR), 1.38 (1.05–1.74)] and correlated positively with 25-hydroxyvitamin D (ρ = 0.31; P < 0.0001). Patients in the lowest decile had higher relapse or death risk [HR, 2.05; 95% confidence interval (CI), 1.10–3.84; P = 0.03] than those in deciles 2 to 10. In the middle range (deciles 6–8), 5-year RFS was greater with vitamin D versus placebo (81.4% vs. 54.9%; HR, 0.31; 95% CI, 0.14–0.69; P = 0.004), with no effect in lower (deciles 1–5) or higher (deciles 9–10) ranges (Pinteraction = 0.008). Conclusions: Vitamin D supplementation may reduce relapse and death among patients with middle-to-upper range of serum vitamin A levels. Impact: These exploratory findings provide the first RCT evidence that serum vitamin A levels modify the effect of vitamin D supplementation on relapse or death among patients with digestive tract cancer.